Integrated Filing — IndAS

General information about company

Scrip Code	544210
NSE Symbol	EMCURE
MSEI Symbol	NOTLISTED
ISIN	INE168P01015
Name of company	EMCURE PHARMACEUTICALS LIMITED
Type of company	Main Board
Class of security	Equity
Date of start of financial year	01-04-2026
Date of end of financial year	31-03-2027
Date of board meeting when results were approved	03-11-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	14-10-2026
Description of presentation currency	INR
Level of rounding used in financial results	Lakhs
Reporting Type	Quarterly
Reporting Quarter	Second quarter
Nature of report standalone or consolidated	Consolidated
Whether results are audited or unaudited for the quarter ended	Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended	Unaudited
Segment Reporting	Single segment
Description of single segment	Pharmaceuticals
Start date and time of board meeting	03-11-2026 12:48:00
End date and time of board meeting	03-11-2026 13:30:00
Whether cash flow statement is applicable on company	Yes
Type of cash flow statement	Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification	Not applicable

Financial Results Ind-AS

Amount in (Lakhs)

Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-07-2026	01-04-2026
B	Date of end of reporting period	30-09-2026	30-09-2026
C	Whether results are audited or unaudited	Unaudited	Unaudited
D	Nature of report standalone or consolidated	Consolidated	Consolidated
1	Income
	Revenue from operations	2,82,047.10	5,40,091.80
	Other income	325.40	532.50
	Total income	2,82,372.50	5,40,624.30
2	Expenses
(a)	Cost of materials consumed	64,212.80	1,12,326.40
(b)	Purchases of stock-in-trade	62,541.40	1,18,053.30
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	(12,516.70)	(8,826.80)
(d)	Employee benefit expense	43,471.00	84,420.50
(e)	Finance costs	3,557.60	6,711.20
(f)	Depreciation, depletion and amortisation expense	10,966.30	21,916.80
(f)	Other Expenses
1	Other expenses	66,863.10	1,25,843.20
2	Net (gain) / loss on foreign currency transactions	(1,308.20)	(3,597.50)
3	Changes in fair value of contingent consideration	0.00	(160.60)
	Total other expenses	65,554.90	1,22,085.10
	Total expenses	2,37,787.30	4,56,686.50
3	Total profit before exceptional items and tax	44,585.20	83,937.80
4	Exceptional items	0.00	0.00
5	Total profit before tax	44,585.20	83,937.80
6	Tax expense
7	Current tax	12,223.50	23,746.80
8	Deferred tax	(145.10)	(1,565.10)
9	Total tax expenses	12,078.40	22,181.70
10	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0.00	0.00
11	Net Profit Loss for the period from continuing operations	32,506.80	61,756.10
12	Profit (loss) from discontinued operations before tax	0.00	0.00
13	Tax expense of discontinued operations	0.00	0.00
14	Net profit (loss) from discontinued operation after tax	0.00	0.00
15	Share of profit (loss) of associates and joint ventures accounted for using equity method	0.00	0.00
16	Total profit (loss) for period	32,506.80	61,756.10
17	Other comprehensive income net of taxes	1,423.80	3,490.90
18	Total Comprehensive Income for the period	33,930.60	65,247.00
19	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent	32,556.50	61,954.50
	Total profit or loss, attributable to non-controlling interests	(49.70)	(198.40)
20	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent	33,980.30	65,445.50
	Total comprehensive income for the period attributable to owners of parent non-controlling interests	(49.70)	(198.50)
21	Details of equity share capital
	Paid-up equity share capital	18,971.10	18,971.10
	Face value of equity share capital	10	10
27	Details of debt securities
22	Reserves excluding revaluation reserve
23	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	17.16	32.67
	Diluted earnings (loss) per share from continuing operations	17.14	32.63
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	17.16	32.67
	Diluted earnings (loss) per share from continuing and discontinued operations	17.14	32.63
24	Debt equity ratio
25	Debt service coverage ratio
26	Interest service coverage ratio
27	Disclosure of notes on financial results		Textual Information(1)

Disclosure of notes on financial results

Textual Information(1)	For detailed notes refer full results uploaded on website of stock exchanges and company.

Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio

Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars		Year ended (dd-mm-yyyy)
Date of start of reporting period		01-04-2026
Date of end of reporting period		30-09-2026
Whether results are audited or unaudited		Unaudited
Nature of report standalone or consolidated		Consolidated
	Assets
1	Non-current assets
	Property, plant and equipment	1,98,565.40
	Capital work-in-progress	32,816.80
	Investment property	0.00
	Goodwill	42,784.00
	Other intangible assets	52,438.00
	Intangible assets under development	11,301.30
	Biological assets other than bearer plants	0.00
	Investments accounted for using equity method	0.00
	Non-current financial assets
	Non-current investments	1,983.30
	Trade receivables, non-current	0.00
	Loans, non-current	0.00
	Other non-current financial assets
1	Other non current financial assets	3,703.70
	Total of other non-current financial assets	3,703.70
	Total non-current financial assets	5,687.00
	Deferred tax assets (net)	14,385.50
	Other non-current assets
1	Right-of-use assets	32,089.50
2	Other non-current assets	12,025.00
	Total of other non-current assets	44,114.50
	Total non-current assets	4,02,092.50
2	Current assets
	Inventories	2,50,463.30
	Current financial asset
	Current investments	0.00
	Trade receivables, current	2,73,144.80
	Cash and cash equivalents	13,658.90
	Bank balance other than cash and cash equivalents	1,075.40
	Loans, current	0.00
	Other current financial assets
	Total of other current financial assets	6,984.90
	Total current financial assets	2,94,864.00
	Current tax assets (net)	11,526.60
	Other current assets
1	Other current assets	57,431.80
	Total of other current assets	57,431.80
	Total current assets	6,14,285.70
3	Non-current assets classified as held for sale	0.00
4	Regulatory deferral account debit balances and related deferred tax Assets	0.00
	Total assets	10,16,378.20
	Equity and liabilities
1	Equity
	Equity attributable to owners of parent
	Equity share capital	18,971.10
	Other equity	5,15,433.00
	Total equity attributable to owners of parent	5,34,404.10
	Non controlling interest	0.00
	Total equity	5,34,404.10
2	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	53,723.40
	Trade payables, non-current
	(A) Total outstanding dues of micro enterprises and small enterprises	0.00
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	0.00
	Total Trade payable	0.00
	Other non-current financial liabilities
1	Lease Liabilities	23,910.50
2	Other non current financial liabilities	6,540.20
	Total of other non-current financial liabilities	30,450.70
	Total non-current financial liabilities	84,174.10
	Provisions, non-current	3,929.80
	Deferred tax liabilities (net)	8,583.40
	Deferred government grants, Non-current	0.00
	Other non-current liabilities
1	Other non-current liabilities	1,393.70
	Total of other non-current liabilities	1,393.70
	Total non-current liabilities	98,081.00
	Current liabilities
	Current financial liabilities
	Borrowings, current	93,006.10
	Trade payables, current
	(A) Total outstanding dues of micro enterprises and small enterprises	8,434.50
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	1,94,200.80
	Total Trade payable	2,02,635.30
	Other current financial liabilities
1	Lease Liabilities	5,042.90
2	Other current financial liabilities	51,938.30
	Total of other current financial liabilities	56,981.20
	Total current financial liabilities	3,52,622.60
	Other current liabilities	12,128.60
1	Other current liabilities	12,128.60
	Total of other current liabilities	12,128.60
	Provisions, current	8,146.20
	Current tax liabilities (Net)	10,995.70
	Deferred government grants, Current	0.00
	Total current liabilities	3,83,893.10
3	Liabilities directly associated with assets in disposal group classified as held for sale	0.00
4	Regulatory deferral account credit balances and related deferred tax liability	0.00
	Total liabilities	4,81,974.10
	Total equity and liabilites	10,16,378.20
	Disclosure of notes on assets and liabilities

Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-07-2026	01-04-2026
Date of end of reporting period		30-09-2026	30-09-2026
Whether results are audited or unaudited		Unaudited	Unaudited
Nature of report standalone or consolidated		Consolidated	Consolidated
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
	Total Segment Revenue
	Less: Inter segment revenue
	Revenue from operations
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
	Total Profit before tax
	i. Finance cost
	ii. Other Unallocable Expenditure net off Unallocable income
	Profit before tax
3	(Segment Asset - Segment Liabilities)
	Segment Asset
	Total Segment Asset
	Un-allocable Assets	null	null
	Net Segment Asset	null	null
4	Segment Liabilities
	Segment Liabilities
	Total Segment Liabilities
	Un-allocable Liabilities	null	null
	Net Segment Liabilities	null	null
	Disclosure of notes on segments

Other Comprehensive Income

Amount in (Lakhs)

Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-07-2026	01-04-2026
B	Date of end of reporting period	30-09-2026	30-09-2026
C	Whether results are audited or unaudited	Unaudited	Unaudited
D	Nature of report standalone or consolidated	Consolidated	Consolidated
	Other comprehensive income [Abstract]
1	Amount of items that will not be reclassified to profit and loss
1	Other comprehensive income / (loss) not to be reclassified to profit or loss	(21.60)	(43.50)
	Total Amount of items that will not be reclassified to profit and loss	(21.60)	(43.50)
2	Income tax relating to items that will not be reclassified to profit or loss	(5.60)	(9.50)
3	Amount of items that will be reclassified to profit and loss
1	Other comprehensive income/(loss) to be reclassified to profit or loss	1,439.80	3,524.90
	Total Amount of items that will be reclassified to profit and loss	1,439.80	3,524.90
4	Income tax relating to items that will be reclassified to profit or loss	0.00	0.00
5	Total Other comprehensive income	1,423.80	3,490.90

Cash flow statement, indirect

Amount in (Lakhs)

Particulars			Year ended (dd-mm-yyyy)
A	Date of start of reporting period		01-04-2026
B	Date of end of reporting period		30-09-2026
C	Whether results are audited or unaudited		Unaudited
D	Nature of report standalone or consolidated		Consolidated
	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax		83,937.80
	Adjustments for reconcile profit (loss)
	Adjustments for finance costs		6,711.20
	Adjustments for decrease (increase) in inventories		(9,024.80)
	Adjustments for decrease (increase) in trade receivables, current		(16,609.90)
	Adjustments for decrease (increase) in trade receivables, non-current		0.00
	Adjustments for decrease (increase) in other current assets		(11,304.30)
	Adjustments for decrease (increase) in other non-current assets		0.00
	Adjustments for other financial assets, non-current		0.00
	Adjustments for other financial assets, current		210.40
	Adjustments for other bank balances		0.00
	Adjustments for increase (decrease) in trade payables, current		19,913.60
	Adjustments for increase (decrease) in trade payables, non-current		0.00
	Adjustments for increase (decrease) in other current liabilities		3,001.30
	Adjustments for increase (decrease) in other non-current liabilities		0.00
	Adjustments for depreciation and amortisation expense		21,916.80
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss		0.00
	Adjustments for provisions, current		746.10
	Adjustments for provisions, non-current		0.00
	Adjustments for other financial liabilities, current		(2,972.10)
	Adjustments for other financial liabilities, non-current		0.00
	Adjustments for unrealised foreign exchange losses gains		668.30
	Adjustments for dividend income		0.00
	Adjustments for interest income		35.40
	Adjustments for share-based payments		410.00
	Adjustments for fair value losses (gains)		0.00
	Adjustments for undistributed profits of associates		0.00
	Other adjustments for which cash effects are investing or financing cash flow		0.00
	Other adjustments to reconcile profit (loss)		0.00
	Other adjustments for non-cash items		(476.00)
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships		0.00
	Total adjustments for reconcile profit (loss)		13,155.20
	Net cash flows from (used in) operations		97,093.00
	Dividends received		0.00
	Interest paid		0.00
	Interest received		0.00
	Income taxes paid (refund)		28,869.10
	Other inflows (outflows) of cash		0.00
	Net cash flows from (used in) operating activities		68,223.90
	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses		11,773.20
	Cash flows used in obtaining control of subsidiaries or other businesses		31,444.40
	Other cash receipts from sales of equity or debt instruments of other entities		0.00
	Other cash payments to acquire equity or debt instruments of other entities		0.00
	Other cash receipts from sales of interests in joint ventures		0.00
	Other cash payments to acquire interests in joint ventures		0.00
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships		0.00
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships		0.00
	Proceeds from sales of property, plant and equipment		232.30
	Purchase of property, plant and equipment		24,526.00
	Proceeds from sales of investment property		0.00
	Purchase of investment property		0.00
	Proceeds from sales of intangible assets		0.00
	Purchase of intangible assets		12,649.40
	Proceeds from sales of intangible assets under development		0.00
	Purchase of intangible assets under development		0.00
	Proceeds from sales of goodwill		0.00
	Purchase of goodwill		0.00
	Proceeds from biological assets other than bearer plants		0.00
	Purchase of biological assets other than bearer plants		0.00
	Proceeds from government grants		0.00
	Proceeds from sales of other long-term assets		0.00
	Purchase of other long-term assets		0.00
	Cash advances and loans made to other parties		0.00
	Cash receipts from repayment of advances and loans made to other parties		0.00
	Cash payments for future contracts, forward contracts, option contracts and swap contracts		0.00
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts		0.00
	Dividends received		0.00
	Interest received		35.40
	Income taxes paid (refund)		0.00
	Other inflows (outflows) of cash		(109.90)
	Net cash flows from (used in) investing activities	(56,688.80)
	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries		0.00
	Payments from changes in ownership interests in subsidiaries		23,233.70
	Proceeds from issuing shares		1,152.10
	Proceeds from issuing other equity instruments		0.00
	Payments to acquire or redeem entity's shares		0.00
	Payments of other equity instruments		0.00
	Proceeds from exercise of stock options		0.00
	Proceeds from issuing debentures notes bonds etc		0.00
	Proceeds from borrowings		38,682.10
	Repayments of borrowings		16,247.60
	Payments of lease liabilities		3,422.70
	Dividends paid		6,829.20
	Interest paid		5,439.50
	Income taxes paid (refund)		0.00
	Other inflows (outflows) of cash		0.00
	Net cash flows from (used in) financing activities		(15,338.50)
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes		(3,803.40)
	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents		152.80
	Net increase (decrease) in cash and cash equivalents		(3,650.60)
	Cash and cash equivalents cash flow statement at beginning of period		9,776.50
	Cash and cash equivalents cash flow statement at end of period		6,125.90